Skip to main content

Table 1 Patient characteristics

From: Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer

Number of patients n = 41
Age Median Range
  69 60–92
Race n %
 Caucasian 26 63%
 African-American 15 37%
Prostate volume (cc) Median Range
  37 20–63
PSA (ng/mL) Median Range
  6.9 3.5–18.3
T Stage n %
 1b 1 2%
 1c 28 68%
 2a 6 15%
 2b 4 10%
 2c 2 5%
Gleason score n %
 3+3 9 22%
 3+4 23 56%
 4+3 9 22%
Number of risk factors* n %
 1 34 83%
 2 7 17%
 3 0 0%
  1. * Factors include PSA 10–20 ng/mL, Gleason 7, or T2b-2c.